Engagement and Drug Development Insights

This chapter emphasizes listener engagement through social media and highlights various outreach options for the audience. It also delves into Biohaven's transition post-sale of its migraine drug to Pfizer, showcasing their ongoing drug development and an insightful interview with Dr. Vlad Chor about future strategies.